AbTree Biologics AG has signed an exclusive co-development and commercialization partnership with Shilpa Biologicals Pvt Ltd.

The global generic pharmaceuticals contract manufacturing market is on an upward trajectory, with a CAGR of 6.15% from 2025 to 2033. As the industry shifts towards more cost-effective and high-quality ...